Results for tag: "Lipoglycopeptides"

Lipoglycopeptides are a class of antibiotics used to treat a variety of bacterial infections. They are composed of a lipophilic side chain attached to a glycopeptide backbone. Lipoglycopeptides are effective against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). They are also used to treat infections caused by vancomycin-resistant enterococci (VRE). The lipoglycopeptides market is driven by the increasing prevalence of antibiotic-resistant bacteria, as well as the growing demand for new and effective antibiotics. The market is also driven by the increasing number of clinical trials and the development of new formulations. The lipoglycopeptides market is highly competitive, with several major players. These include Merck & Co., Inc., Pfizer Inc., AstraZeneca plc, GlaxoSmithKline plc, Sanofi S.A., and Novartis AG. Show Less Read more